HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to tame head and neck cancer with fewer side effects
Disease control Not yet recruitingThis study tests a combination of the immunotherapy drug toripalimab with two chemotherapy drugs (cisplatin and docetaxel) as an initial treatment for people with advanced head and neck cancer that has a specific marker (CPS-positive). The goal is to see if this approach is safe …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Dental program aims to ease cancer survivors' mouth problems
Disease control Not yet recruitingThis study tests whether extra dental support for head and neck cancer survivors can prevent or reduce late side effects like tooth loss, jaw stiffness, and cavities. Researchers will compare a special oral care program (visits every three months for three years) to standard care…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC